Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

An Open-label, First-in-human, Dose-escalation/Expansion Study of SAR443579 Administered as Single Agent by Intravenous Infusion in Adult and Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05086315
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-07-07T00:07:33.255773+00:00
Published At
2026-07-06T00:00:00+00:00
Record Updated At
2026-07-06
Results Posted At
2026-07-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Lymphocytic Leukaemia", "Acute Myeloid Leukaemia Refractory", "Myelodysplastic Syndromes", "Blastic Plasmacytoid Dendritic Cell Neoplasia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-07-06"
protocolSection.identificationModule.nctId
"NCT05086315"
protocolSection.identificationModule.officialTitle
"An Open-label, First-in-human, Dose-escalation/Expansion Study of SAR443579 Administered as Single Agent by Intravenous Infusion in Adult and Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-07-06"

Study condition terms

  • Acute Lymphocytic Leukaemia (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukaemia Refractory (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
  • Blastic Plasmacytoid Dendritic Cell Neoplasia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.